Skip to main content
. 2020 Nov 26;2:602182. doi: 10.3389/fgeed.2020.602182

Figure 2.

Figure 2

Treatment strategy for genome engineering of autologous HSC of GATA2 haploinsufficiency patients with safety considerations.